Evenity (romosozumab-aqqg) is a prescription injection used to treat postmenopausal osteoporosis. Evenity’s cost may depend on factors such as whether you have health insurance and which ...

Amgen and UCB finally have FDA approval for osteoporosis drug Evenity, two years after it was turned down by the regulator because of safety concerns. The agency approved Evenity (romosozumab ...

UCB and Amgen’s osteoporosis drug Evenity has finally been approved in Europe, following a successful appeal against a regulatory rejection, to become the first new drug for the condition since ...